Consistent with these findings, our results also showed that TMZ treatment, alone or in combination with MTX, significantly (p < 0.001) decreased the expression levels of downstream inflammatory biomarkers TRAF6 and IRAK in paw tissues, compared to the FCA-induced RA model (Figure 3). Here, TRAF6 is linked to rheumatoid arthritis.